Ribbon Biolabs are developing a new technology to synthesize DNA molecules...
Continue Reading-
Ribbon Biolabs raises EUR 18 million in its Series A financing
Ribbon Biolabs Raises EUR 18 Million Series A Financing
Continue Reading -
EMERGENCE THERAPEUTICS
Emergence Therapeutics is a European biopharmaceutical company...
Continue Reading -
Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC
Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC — Hadean Ventures…
Continue Reading -
Hadean Ventures Announces the 1st Closing of EUR 90m for its Second Fund
Hadean Ventures Announces the 1st Closing of EUR 90m for its Second Fund...
Continue Reading -
Cardior raises €64 M Series B to advance clinical pipeline of RNA therapeutics to treat Cardiac Disease
Cardior raises €64 M Series B to advance clinical pipeline of RNA therapeutics to treat…
Continue Reading -
Attgeno appoints Björn Westberg as CFO
Attgeno appoints Björn Westberg as CFO — Hadean Ventures Home Portfolio Team Impact Investors News…
Continue Reading -
Oncoinvent Secures NOK 250 M in an oversubscribed Pre-IPO Funding Round
Oncoinvent Secures NOK 250 M in an oversubscribed Pre-IPO Funding Round — Hadean Ventures Home…
Continue Reading -
SAGA Diagnostics raises €10.5 million
SAGA Diagnostics raises SEK 106 million (€10.5 million)...
Continue Reading -
Gesynta Pharma announces significant progress across development program for first-in-class drug candidate GS-248
Gesynta Pharma announces significant progress across development program for first-in-class drug candidate GS-248 — Hadean…
Continue Reading